Suppr超能文献

疾病突变分析揭示了DAXX在端粒酶调控和端粒维持中的新功能。

Disease mutant analysis identifies a new function of DAXX in telomerase regulation and telomere maintenance.

作者信息

Tang Mengfan, Li Yujing, Zhang Yi, Chen Yuxi, Huang Wenjun, Wang Dan, Zaug Arthur J, Liu Dan, Zhao Yong, Cech Thomas R, Ma Wenbin, Songyang Zhou

机构信息

Key Laboratory of Gene Engineering of the Ministry of Education and State Key Laboratory for Biocontrol, School of Life Sciences, Sun Yat-sen University, Guangzhou 510275, China.

Verna and Marrs Department of Biochemistry and Molecular biology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA.

出版信息

J Cell Sci. 2015 Jan 15;128(2):331-41. doi: 10.1242/jcs.159467. Epub 2014 Nov 21.

Abstract

Most human cancers depend on the telomerase to maintain telomeres; however, about 10% of cancers are telomerase negative and utilize the alternative lengthening of telomeres (ALT) mechanism. Mutations in the DAXX gene have been found frequently in both telomerase-positive and ALT cells, and how DAXX mutations contribute to cancers remains unclear. We report here that endogenous DAXX can localize to Cajal bodies, associate with the telomerase and regulate telomerase targeting to telomeres. Furthermore, disease mutations that are located in different regions of DAXX differentially impact on its ability to interact with its binding partners and its targeting to Cajal bodies and telomeres. In addition, DAXX knockdown by RNA interference led to reduced telomerase targeting to telomeres and telomere shortening. These findings collectively support a DAXX-centric pathway for telomere maintenance, where DAXX interaction with the telomerase regulates telomerase assembly in Cajal bodies and telomerase targeting to telomeres.

摘要

大多数人类癌症依赖端粒酶来维持端粒;然而,约10%的癌症是端粒酶阴性的,并利用端粒替代延长(ALT)机制。DAXX基因的突变在端粒酶阳性细胞和ALT细胞中都频繁被发现,而DAXX突变如何导致癌症仍不清楚。我们在此报告,内源性DAXX可定位于卡哈尔体,与端粒酶结合并调节端粒酶靶向端粒。此外,位于DAXX不同区域的疾病突变对其与结合伴侣相互作用的能力以及其靶向卡哈尔体和端粒的能力有不同影响。另外,通过RNA干扰敲低DAXX导致端粒酶靶向端粒减少以及端粒缩短。这些发现共同支持了一条以DAXX为中心的端粒维持途径,其中DAXX与端粒酶的相互作用调节端粒酶在卡哈尔体中的组装以及端粒酶靶向端粒。

相似文献

1
Disease mutant analysis identifies a new function of DAXX in telomerase regulation and telomere maintenance.
J Cell Sci. 2015 Jan 15;128(2):331-41. doi: 10.1242/jcs.159467. Epub 2014 Nov 21.
3
ATRX represses alternative lengthening of telomeres.
Oncotarget. 2015 Jun 30;6(18):16543-58. doi: 10.18632/oncotarget.3846.
4
Loss of DAXX and ATRX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors.
Gastroenterology. 2014 Feb;146(2):453-60.e5. doi: 10.1053/j.gastro.2013.10.020. Epub 2013 Oct 19.
7
Altered telomeres in tumors with ATRX and DAXX mutations.
Science. 2011 Jul 22;333(6041):425. doi: 10.1126/science.1207313. Epub 2011 Jun 30.
8
Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies.
Genome Med. 2016 Jun 20;8(1):69. doi: 10.1186/s13073-016-0324-x.
9
Alternative lengthening of telomeres and ATRX/DAXX loss can be reliably detected in FNAs of pancreatic neuroendocrine tumors.
Cancer Cytopathol. 2017 Jul;125(7):544-551. doi: 10.1002/cncy.21857. Epub 2017 Apr 3.

引用本文的文献

2
Contribution of histone variants to aneuploidy: a cancer perspective.
Front Genet. 2023 Nov 23;14:1290903. doi: 10.3389/fgene.2023.1290903. eCollection 2023.
3
DAXX-ATRX regulation of p53 chromatin binding and DNA damage response.
Nat Commun. 2022 Aug 26;13(1):5033. doi: 10.1038/s41467-022-32680-8.
6
Regulation of telomere homeostasis and genomic stability in cancer by -adenosine methylation (mA).
Sci Adv. 2021 Jul 28;7(31). doi: 10.1126/sciadv.abg7073. Print 2021 Jul.
7
Current status of ctDNA in precision oncology for hepatocellular carcinoma.
J Exp Clin Cancer Res. 2021 Apr 26;40(1):140. doi: 10.1186/s13046-021-01940-8.
8
HuB and HuD repress telomerase activity by dissociating HuR from TERC.
Nucleic Acids Res. 2021 Mar 18;49(5):2848-2858. doi: 10.1093/nar/gkab062.
9
A critical role of telomere chromatin compaction in ALT tumor cell growth.
Nucleic Acids Res. 2020 Jun 19;48(11):6019-6031. doi: 10.1093/nar/gkaa224.

本文引用的文献

1
Integrated genomic characterization of adrenocortical carcinoma.
Nat Genet. 2014 Jun;46(6):607-12. doi: 10.1038/ng.2953. Epub 2014 Apr 20.
3
Structure of the variant histone H3.3-H4 heterodimer in complex with its chaperone DAXX.
Nat Struct Mol Biol. 2012 Dec;19(12):1287-92. doi: 10.1038/nsmb.2439. Epub 2012 Nov 11.
4
The TEL patch of telomere protein TPP1 mediates telomerase recruitment and processivity.
Nature. 2012 Dec 13;492(7428):285-9. doi: 10.1038/nature11648. Epub 2012 Oct 24.
5
DAXX envelops a histone H3.3-H4 dimer for H3.3-specific recognition.
Nature. 2012 Nov 22;491(7425):560-5. doi: 10.1038/nature11608. Epub 2012 Oct 17.
6
Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing.
Cell. 2012 Sep 14;150(6):1107-20. doi: 10.1016/j.cell.2012.08.029.
8
Antitelomerase therapy provokes ALT and mitochondrial adaptive mechanisms in cancer.
Cell. 2012 Feb 17;148(4):651-63. doi: 10.1016/j.cell.2011.12.028.
9
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma.
Nature. 2012 Jan 29;482(7384):226-31. doi: 10.1038/nature10833.
10
Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing.
Nature. 2012 Jan 11;481(7382):506-10. doi: 10.1038/nature10738.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验